in5points
FinanceAsianet Newsable

SLS Stock Tracks Worst Month Since March: Investor Slashes Stake By Over 30% As Quiet Period Begins Ahead Of AML Readout

in5points

  1. Sellas Life Sciences stock had its worst month since March.

  2. An investor reduced its stake by over 30% during a quiet period.

  3. The quiet period precedes an AML readout for SLS009.

  4. Sellas is preparing for database lock and potential BLA-related regulatory work.

  5. Development of SLS009, its second AML drug, is ongoing.

12h ago · original ↗
SLS Stock Tracks Worst Month Since March: Investor Slashes Stake By Over 30% As Quiet Period Begins Ahead… · in5points